The case-patient showed a moderate clinical presentation of yellow fever. He had fever, headache, body pain, anorexia, dizziness, bitterness in the mouth, and dark yellow urine. The patient was no longer able to eat solid food during a 3-day period. Initial laboratory test results showed a platelet count 55,000/mm 3 ; basophil count 100 cells/mm 3 (reference range 0.0-0.2
Liver ultrasonography showed a moderate degree of fatty liver infiltration. Doppler imaging showed normal portal vein flow. On day 11 post-onset of symptoms (dps 11) he started eating solid food again and his urine showed a standard color. Normalization of his platelet count was observe on dps 12, and aminotransferase levels within reference ranges were observed on dps 39. During dps 13-dps 76, the patient reported having episodes of fever, dizziness, headaches, and bitterness in the mouth, especially during physical excursion. He also reported a loss of taste.
Next-Generation Sequencing
To obtain the complete genome sequence, virus RNA was reextracted from the urine sample by using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA), purified with (https://bioweb.pasteur.fr/packages/pack@FastTree@2.1.8).
Virus isolation in Cell Culture
We attempted to isolate YFV from the positive urine sample on day 21 after onset of patient symptoms to confirm the presence of infectious virus. The sample was initially treated with 100× Antibiotic-Antimycotic (Gibco, Gaithersburg, MD, USA) for 1 h on ice. For virus isolation, a Vero-E6 cell culture was maintained in 25-cm 2 flakes by using high-glycoside Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Gibco), 1%
nonessential amino acids (Gibco), and 1% sodium pyruvate (Gibco) and maintained at 37°C in an atmosphere of 5% CO2. After reaching 90% confluence in the monolayer, we prepared a 1:3 mixture with pure Dulbecco's modified Eagle's medium (pH 8.2), inoculated the mixture into Vero-E6 cells, and incubated the mixture for 1 h with gentle shaking every 10 min to enable homogeneous adsorption of viruses. At the end of the adsorption period, 5 mL of the culture medium (pH 7.2), plus 2% fetal bovine serum, 1% nonessential amino acids, and 1% sodium pyruvate were added. The sample was passed 2 times in cell culture and after 7 days of Page 3 of 3 incubation, cells were collected and tested for YFV by using a real-time quantitative reverse transcription PCR and a standard PCR.
